Literature DB >> 7668839

Diabetic polyneuropathy in controlled clinical trials: Consensus Report of the Peripheral Nerve Society.

.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7668839     DOI: 10.1002/ana.410380323

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  16 in total

Review 1.  Diabetic neuropathy part 1: overview and symmetric phenotypes.

Authors:  Mamatha Pasnoor; Mazen M Dimachkie; Patricia Kluding; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-03-15       Impact factor: 3.806

Review 2.  Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).

Authors:  Alejandra Gonzalez-Duarte
Journal:  Clin Auton Res       Date:  2018-03-06       Impact factor: 4.435

Review 3.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

4.  Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy.

Authors:  E Bosi; M Conti; C Vermigli; G Cazzetta; E Peretti; M C Cordoni; G Galimberti; L Scionti
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

5.  Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area.

Authors:  A Cortese; G Vita; M Luigetti; M Russo; G Bisogni; M Sabatelli; F Manganelli; L Santoro; T Cavallaro; G M Fabrizi; A Schenone; M Grandis; C Gemelli; A Mauro; L G Pradotto; L Gentile; C Stancanelli; A Lozza; S Perlini; G Piscosquito; D Calabrese; A Mazzeo; L Obici; D Pareyson
Journal:  J Neurol       Date:  2016-03-16       Impact factor: 4.849

6.  Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.

Authors:  Teresa Coelho; Luis F Maia; Ana Martins da Silva; Marcia Waddington Cruz; Violaine Planté-Bordeneuve; Pierre Lozeron; Ole B Suhr; Josep M Campistol; Isabel Maria Conceição; Hartmut H-J Schmidt; Pedro Trigo; Jeffery W Kelly; Richard Labaudinière; Jason Chan; Jeff Packman; Amy Wilson; Donna R Grogan
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

7.  Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Authors:  John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

8.  A trial of proficiency of nerve conduction: greater standardization still needed.

Authors:  Peter J Dyck; James W Albers; James Wolfe; Charles F Bolton; Nancy Walsh; Christopher J Klein; Andrew J Zafft; James W Russell; Karen Thomas; Jenny L Davies; Rickey E Carter; L Joseph Melton; William J Litchy
Journal:  Muscle Nerve       Date:  2013-07-17       Impact factor: 3.217

9.  Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study.

Authors:  Antonio Memeo; Mario Loiero
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

10.  Diagnostic approach to peripheral neuropathy.

Authors:  Usha Kant Misra; Jayantee Kalita; Pradeep P Nair
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.